Balanced news tone
News Sentiment
219A sentiment intelligence
HEARTSEED INC news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
53
Balanced news tone
6 relevant articles
News tone and price action are not far from neutral.
73/100 classification confidence.
directly relevant articles
high-authority source matches
-2.0% over one week, +0.4% over four weeks, trend inactive, and below fair value.
ETFs Investing in Heartseed, Inc. Stocks
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
73/100 classification
One-week reaction
-2.0%
Price reacting lower
Trend fit
Trend inactive
0.4% over four weeks
Fair value
-24.1%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
1
Neutral
5
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
TradingView
Direct company coverage
ETFs Investing in Heartseed, Inc. Stocks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 22:40
- Source
- TradingView
BioSpace
Direct company coverage
Heartseed, World's First Clinical Trial of Catheter Administration of iPSC-Derived Cardiomyocyte Spheroids: First Patient Dosed
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jun 2026 07:00
- Source
- BioSpace
BioInformant
Direct company coverage
Novo Nordisk Ends $598M Heartseed Partnership to Refocus Strategic Priorities
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 24 Dec 2025 08:00
- Source
- BioInformant
BioWorld News
Direct company coverage
Novo ends Heartseed deal for iPS cell-derived cardiomyocytes
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 30 Sep 2025 07:00
- Source
- BioWorld News
Business Wire
Direct company coverage
Heartseed raises 2 billion JPY in series D funding to accelerate development of iPSC-derived stem cell therapy for heart failure
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 25 May 2023 07:00
- Source
- Business Wire
pharmaphorum
Direct company coverage
Heart hope for Heartseed/Novo Nordisk HS-001 cell therapy
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Feb 2023 08:00
- Source
- pharmaphorum